Novozymes A/S
CSE:NZYM B
Novozymes A/S
Cost of Revenue
Novozymes A/S
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novozymes A/S
CSE:NZYM B
|
Cost of Revenue
-kr8.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Chr Hansen Holding A/S
CSE:CHR
|
Cost of Revenue
-€611.1m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-6%
|
See Also
What is Novozymes A/S's Cost of Revenue?
Cost of Revenue
-8.2B
DKK
Based on the financial report for Dec 31, 2023, Novozymes A/S's Cost of Revenue amounts to -8.2B DKK.
What is Novozymes A/S's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%
Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Novozymes A/S have been -10% over the past three years , -6% over the past five years .